You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
The assay from San Diego-based Cue is the first molecular test authorized by the US Food and Drug Administration for home use without a doctor's prescription.
In December, the firm was named a finalist in a $6 million Xprize competition to develop a rapid test for detecting SARS-CoV-2.
The University of Birmingham-developed method combines a method called EXPAR with a rapid upfront step to obviate reverse transcription.
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progressed, more funding became available, and collaboration accelerated.
The Solana SARS-CoV-2 test can be run in batches of 11 samples, with minimum hands on time, no extraction, and results in approximately 25 minutes.
The GeneMe assay, called FRANKD, is currently being used to test Virgin Atlantic pilots and crew of certain routes departing Heathrow Airport.
The loop-mediated isothermal amplification test runs on a battery-powered device to provide self-testing individuals with results in approximately 30 minutes.
The diagnostics are capable of detecting fewer than two parasites per microliter of blood and would cost an estimated $.61 per test.
One of the revisions specifies that the ID Now test is for use with specimens collected within the first week of symptom onset.